Enoxaparin or unfractioned heparin in patients with acute coronary events

被引：0
|
作者：
Gurfinkel, E
Rossi, A
Duronto, E
Martinuzzo, M
Cerrato, G
Cohen, M
Mautner, B
机构：
[1] FDN FAVALORO, BUENOS AIRES, DF, ARGENTINA
[2] ALLENTOWN HOSP, ALLENTOWN, PA 18102 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P1189 / P1189
页数：1
相关论文
共 50 条
  • [31] Enoxaparin in acute coronary syndromes
    Lee, Sinjin
    Gibson, C. Michael
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2007, 5 (03) : 387 - 399
  • [32] Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin - Effect on platelet function and thrombus formation
    Lev, EI
    Hasdai, D
    Scapa, E
    Tobar, A
    Assali, A
    Battler, A
    Badimon, JJ
    Kornowski, R
    CIRCULATION, 2003, 108 (17) : 577 - 577
  • [33] Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin - Effect on platelet function and thrombus formation
    Lev, EI
    Hasdai, D
    Scapa, E
    Tobar, A
    Assali, A
    Lahav, J
    Battler, A
    Badimon, JJ
    Kornowski, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) : 966 - 971
  • [34] Enoxaparin for acute coronary syndromes?
    Pechlaner, C
    Gritsch, W
    Wiedermann, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 2007 - 2007
  • [35] The greatest benefit of enoxaparin (low molecular weight heparin) over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST segment depression
    Goodman, SG
    Bozovich, G
    Tan, M
    Dos Santos, A
    Hassan, Q
    Naebkhil, A
    Cohen, M
    Langer, A
    Bigonzi, F
    CIRCULATION, 2001, 104 (17) : 549 - 549
  • [36] Low molecular weight heparin (Dalteparin, Enoxaparin) and unfractionated heparin in acute coronary syndromes without ST segment elevation
    Poponina, TM
    Markov, VA
    Antipov, SI
    Staroha, EA
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 615 - 619
  • [37] Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS)
    Bertel, Osmund
    Ramsay, David
    Wettstein, Tobias
    Kurz, David J.
    Stettler, Irene
    Straumann, Edwin
    Frielingsdorf, Juergen
    Maurer, Dominik
    Naegeli, Barbara
    EUROINTERVENTION, 2010, 6 (03) : 407 - 412
  • [38] ESTABLISHING APTT THERAPEUTIC RANGE FOR PATIENTS RECEIVING STANDARD UNFRACTIONED HEPARIN
    Orescanin, B. Jankovic
    Ille, K.
    Obradovic, G. Spasic
    THROMBOSIS RESEARCH, 2014, 133 : S90 - S90
  • [39] Heparin or Enoxaparin Anticoagulation for Primary Percutaneous Coronary Intervention
    Brieger, David
    Collet, Jean-Philippe
    Silvain, Johanne
    Landivier, Antoine
    Barthelemy, Olivier
    Beygui, Farzin
    Bellemain-Appaix, Anne
    Mercadier, Anne
    Choussat, Remi
    Vignolles, Nicolas
    Costagliola, Dominique
    Montalescot, Gilles
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (02) : 182 - 190
  • [40] Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention
    Li Zhi-Zhong
    Tao Ying
    Wang Su
    Yin Cheng-Qian
    Gao Yu-Long
    Cheng Yu-Tong
    Li Zhao
    Ma Chang-Sheng
    中华医学杂志英文版, 2018, 131 (20) : 2417 - 2423
12345